WO2002072622A3 - Invention - Google Patents

Invention Download PDF

Info

Publication number
WO2002072622A3
WO2002072622A3 PCT/GB2002/000597 GB0200597W WO02072622A3 WO 2002072622 A3 WO2002072622 A3 WO 2002072622A3 GB 0200597 W GB0200597 W GB 0200597W WO 02072622 A3 WO02072622 A3 WO 02072622A3
Authority
WO
WIPO (PCT)
Prior art keywords
chlamydia trachomatis
against infection
vaccine antigens
antigens against
vaccines
Prior art date
Application number
PCT/GB2002/000597
Other languages
English (en)
Other versions
WO2002072622A2 (fr
Inventor
Gareth Ewart Jones
Original Assignee
Yaba Ltd
Gareth Ewart Jones
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yaba Ltd, Gareth Ewart Jones filed Critical Yaba Ltd
Priority to AU2002229958A priority Critical patent/AU2002229958A1/en
Publication of WO2002072622A2 publication Critical patent/WO2002072622A2/fr
Publication of WO2002072622A3 publication Critical patent/WO2002072622A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56927—Chlamydia
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/571—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses for venereal disease, e.g. syphilis, gonorrhoea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/295—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Chlamydiales (o)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des peptides immunogéniques dérivés de chlamydia trachomatis. L'invention concerne également leur utilisation dans des vaccins ainsi que les vaccins eux-mêmes, et des procédés de vaccination de sujets faisant appel à de tels vaccins.
PCT/GB2002/000597 2001-02-12 2002-02-12 Invention WO2002072622A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002229958A AU2002229958A1 (en) 2001-02-12 2002-02-12 Vaccine antigens against infection by chlamydia trachomatis

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0103387.7A GB0103387D0 (en) 2001-02-12 2001-02-12 Invention
GB0103387.7 2001-02-12

Publications (2)

Publication Number Publication Date
WO2002072622A2 WO2002072622A2 (fr) 2002-09-19
WO2002072622A3 true WO2002072622A3 (fr) 2003-04-17

Family

ID=9908537

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2002/000597 WO2002072622A2 (fr) 2001-02-12 2002-02-12 Invention
PCT/GB2002/000600 WO2002065129A2 (fr) 2001-02-12 2002-02-12 Procedes

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/GB2002/000600 WO2002065129A2 (fr) 2001-02-12 2002-02-12 Procedes

Country Status (3)

Country Link
AU (2) AU2002229958A1 (fr)
GB (1) GB0103387D0 (fr)
WO (2) WO2002072622A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002331950A1 (en) * 2002-09-17 2004-04-08 Yaba Limited Vaccine

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348725A2 (fr) * 1988-06-29 1990-01-03 Miles Inc. Epitode spécifique de l'espèce de chlamydia trachomatis et les anticorps le reconnaissant
WO1999000414A1 (fr) * 1997-06-19 1999-01-07 Savyon Diagnostics Ltd. Peptides specifiques a chlamydia trachomatis et leur utilisation dans des methodes diagnostiques
US5869608A (en) * 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ954000A0 (en) * 2000-08-18 2000-09-14 Queensland University Of Technology Novel diagnostic agents and uses therefor

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0348725A2 (fr) * 1988-06-29 1990-01-03 Miles Inc. Epitode spécifique de l'espèce de chlamydia trachomatis et les anticorps le reconnaissant
US5869608A (en) * 1989-03-17 1999-02-09 The United States Of America As Represented By The Department Of Health And Human Services Nucleotide and amino acid sequences of the four variable domains of the major outer membrane proteins of Chlamydia trachomatis
WO1999000414A1 (fr) * 1997-06-19 1999-01-07 Savyon Diagnostics Ltd. Peptides specifiques a chlamydia trachomatis et leur utilisation dans des methodes diagnostiques

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 November 1996 (1996-11-01), XP002217201, Database accession no. Q46421 *
YUAN Y ET AL.: "Nucleotide and Deduced Amino Acid Sequence for the Four Variable Domains of the Major Outer Membrane Proteins of the 15 Chlamydia trachomatis Serovars", INFECTION AND IMMUNITY, vol. 57, no. 4, April 1989 (1989-04-01), pages 1040 - 1049, XP000608434 *

Also Published As

Publication number Publication date
WO2002065129A3 (fr) 2003-04-24
WO2002065129A2 (fr) 2002-08-22
AU2002229958A1 (en) 2002-09-24
GB0103387D0 (en) 2001-03-28
AU2002229961A1 (en) 2002-08-28
WO2002072622A2 (fr) 2002-09-19

Similar Documents

Publication Publication Date Title
WO2001060402A3 (fr) Vaccin antigrippal a base de proteosomes
EP1246644A4 (fr) Reponse immunitaire cellulaire au papillomavirus humain induite par utilisation de compositions peptidiques et d'acide nucleique
NO20015073L (no) Vaksiner
DE60012042D1 (de) Entepneumovirus und entsprechendes impfstoff
WO2002009746A8 (fr) Composition vaccinale
WO2001082963A3 (fr) Synchronisation d'epitopes dans des cellules presentant des antigenes
WO2003028760A3 (fr) Vaccin
WO2005089164A3 (fr) Induction de reponses immunitaires cellulaires au papillomavirus humain utilisant des compositions peptidiques et d'acides nucleiques
WO2000057917A3 (fr) Compositions d'adjuvant et methodes permettant d'accentuer les reponses immunitaires a des vaccins a base de polynucleotides
WO2003059381A3 (fr) Préparations immunogènes et vaccins à base d'arn
WO1999010375A3 (fr) Vaccin
WO2003002065A3 (fr) Compositions de vaccin vhc e1e2
PT1409692E (pt) Novos péptidos do derivados da proteína g do vírus respiratório sincicial (vrs) e sua utilização numa vacina
WO2007008918A3 (fr) Vaccins de virus comprenant des proteines immunomodulatrices reliees a une enveloppe, et methode d'utilisation associee
WO2002087494A3 (fr) Nouveau vaccin
WO2001062283A3 (fr) Nouvelle formulation d'adjuvant des muqueuses, non antigenique, modulant l'effet de substances, y compris d'antigenes de vaccin, en contact avec les surfaces de muqueuses
WO2002034773A3 (fr) Genes streptococciques
EP1471936A4 (fr) Vaccin contre le vih et procede d'utilisation
WO2004032860A3 (fr) Formulations de vaccin anti-vih
WO2005058349A3 (fr) Vaccin
WO2002076485A3 (fr) Vaccin assurant la modulation entre des reponses immunitaires t1 et t2
WO2003083083A3 (fr) Procedes d'utilisation d'un ligand flt3 dans des protocoles d'immunisation
WO2001070265A3 (fr) Adjuvants lipopeptidiques
WO1997047271A3 (fr) Vaccins cellulaires immunotherapeutiques et leurs procedes de preparation
WO2002072622A3 (fr) Invention

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP